Showing results (1381-1390 of 1,421) with videos related to
Sort By:
Pageof 143
Gut|January 29, 2025
Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitisIbrahim Al Bakir, Kit Curtius, George D Cresswell, et al.Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Low coverage whole genome sequencing of low-grade dysplasia strongly predicts colorectal cancer risk in ulcerative colitisIbrahim Al Bakir, Kit Curtius, George D Cresswell, et al.Trials|September 30, 2023
Implementation and evaluation of a multi-level mental health promotion intervention for the workplace (MENTUPP): study protocol for a cluster randomised controlled trialElla Arensman, Mallorie Leduc, Cliodhna O'Brien, et al.Wellcome Open Research|October 22, 2020
High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)Suzaan Marais, Fiona V Cresswell, Raph L Hamers, et al.Communications Biology|July 7, 2026
Loss of endothelial ZEB1 enhances neovascularisation during choroidal neovascularisationNicholas Beazley-Long, Joseph L Horder, Kathryn R Green, et al.Nature|October 26, 2022
The co-evolution of the genome and epigenome in colorectal cancerTimon Heide, Jacob Househam, George D Cresswell, et al.Journal of Global Health|May 24, 2023
Feasibility and acceptability of bubble continuous positive airway pressure oxygen therapy for the treatment of childhood severe pneumonia and hypoxaemia in Bangladeshi childrenMohammod Jobayer Chisti, Trevor Duke, Ahmed Ehnasur Rahman, et al.BMJ Open|October 7, 2025
Continuous physiological monitoring for the detection of postoperative deterioration: a protocol for a multistage, multicentre, international, prospective cohort studyAfra Jiwa, Malcolm M Cameron, Adesoji O Ademuyiwa, et al.The Lancet. HIV|June 25, 2026
Cost-effectiveness of emergency department opt-out testing for HIV in England: a modelling studyJosephine G Walker, Rebecca F Baggaley, Gareth Myring, et al.Gut|November 17, 2020
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancersElizabeth C Smyth, Georgios Vlachogiannis, Somaieh Hedayat, et al.Pageof 143